BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair.
Location: Belgium, Wallonia
Employees: 11-50
Founded date: 2006
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 12.03.2024 | BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease | - |
| 02.02.2024 | BioSenic raises €500,000 in private placement of new shares with established new investors | - |
| 18.04.2023 | Biosenic Receives Key European Patent From EPO, For Further Therapeutic Development In Cancer, Infectious And Immune Diseases | Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to maintain therapeuti... |